An organization that is “dedicated to promoting proper antibiotic use and curbing antibiotic resistance worldwide... by raising public awareness through education and research projects on proper antibiotic use and antibiotic resistance.” (http://www.healthsci.tufts.edu/apua/)
According to its website, APUA projects are made possible through the support of private donations, government grants, individual memberships, and unrestricted grants from the following contributors:
- AB Biodisk
- Bristol-Myers Squibb Co.
- The Clorox Company
- LIBRA Initiative, Bayer AG, Pharmaceutical Division
- Lilly Research Laboratories
- Ortho-McNeil Pharmaceutical Inc. and the R.W. Johnson Pharmaceutical Research Institute of Johnson & Johnson
- Pharmacia Corporation
- Procter & Gamble Pharmaceuticals
- Roche Pharmaceuticals and Roche Labs
- Abbott Laboratories
- Paratek Pharmaceuticals, Inc.
- Alcon Research, Ltd.
- Burstein Technologies, Inc.
- Cubist Pharmaceuticals, Inc.
- DSM Anti-Infectives, B.V.
- Essential Therapeutics, Inc.
- Wyeth-Ayerst Research
(http://www.healthsci.tufts.edu/apua/About_us/corporations.html; accessed 7/16/02)
APUA formed a coalition with Bristol-Myers Squibb, SmithKline Beecham, and the infectious diseases services company MRL to create the Global Advisory on Antibiotic Resistance Data (GAARD) to monitor antibiotic resistance (Reuters Health, Sept. 18, 2000)